Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia

Clinical trial NCT00464113 · TERMINATED

Trial details

NCT number: NCT00464113
Sponsor: Exelixis
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia Leukemia, Lymphoblastic, Acute, Philadelphia-Positive

Start date: 2007-05-01
Primary completion: 2010-12-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.